Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8926 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD6651 |
Approved |
0.8571 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8542 |
High Similarity |
NPD1549 |
Phase 2 |
0.8487 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8446 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8411 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8356 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8276 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8247 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8089 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8079 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8079 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8056 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8025 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7919 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7875 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7867 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7742 |
Intermediate Similarity |
NPD920 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7707 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7688 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7679 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7671 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7651 |
Intermediate Similarity |
NPD7054 |
Approved |
0.764 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7625 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD7472 |
Approved |
0.76 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5710 |
Approved |
0.756 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD6099 |
Approved |
0.755 |
Intermediate Similarity |
NPD6100 |
Approved |
0.755 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7535 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.744 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7386 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD919 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7207 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7102 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7072 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6994 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1613 |
Approved |
0.6993 |
Remote Similarity |
NPD943 |
Approved |
0.6993 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.698 |
Remote Similarity |
NPD3266 |
Approved |
0.698 |
Remote Similarity |
NPD3267 |
Approved |
0.697 |
Remote Similarity |
NPD37 |
Approved |
0.6964 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6962 |
Remote Similarity |
NPD2654 |
Approved |
0.6959 |
Remote Similarity |
NPD2403 |
Approved |
0.6948 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6946 |
Remote Similarity |
NPD4965 |
Approved |
0.6946 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD4966 |
Approved |
0.6943 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6928 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD7003 |
Approved |
0.6915 |
Remote Similarity |
NPD7584 |
Approved |
0.6913 |
Remote Similarity |
NPD3225 |
Approved |
0.6909 |
Remote Similarity |
NPD5889 |
Approved |
0.6909 |
Remote Similarity |
NPD5890 |
Approved |
0.6901 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD4288 |
Approved |
0.6879 |
Remote Similarity |
NPD5404 |
Approved |
0.6879 |
Remote Similarity |
NPD5406 |
Approved |
0.6879 |
Remote Similarity |
NPD5408 |
Approved |
0.6879 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD5405 |
Approved |
0.6871 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6842 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD1933 |
Approved |
0.6839 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD4287 |
Approved |
0.6818 |
Remote Similarity |
NPD6104 |
Discontinued |
0.681 |
Remote Similarity |
NPD6273 |
Approved |
0.6803 |
Remote Similarity |
NPD17 |
Approved |
0.6782 |
Remote Similarity |
NPD7228 |
Approved |
0.6782 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6781 |
Remote Similarity |
NPD9545 |
Approved |
0.6779 |
Remote Similarity |
NPD3972 |
Approved |
0.6774 |
Remote Similarity |
NPD6782 |
Approved |
0.6774 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6774 |
Remote Similarity |
NPD6777 |
Approved |
0.6774 |
Remote Similarity |
NPD6779 |
Approved |
0.6774 |
Remote Similarity |
NPD6778 |
Approved |
0.6774 |
Remote Similarity |
NPD6776 |
Approved |
0.6774 |
Remote Similarity |
NPD6781 |
Approved |
0.6774 |
Remote Similarity |
NPD6780 |
Approved |
0.6772 |
Remote Similarity |
NPD4477 |
Approved |
0.6772 |
Remote Similarity |
NPD4476 |
Approved |
0.6755 |
Remote Similarity |
NPD1164 |
Approved |
0.6754 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6753 |
Remote Similarity |
NPD3764 |
Approved |
0.6747 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6744 |
Remote Similarity |
NPD3787 |
Discontinued |
0.674 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.673 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6722 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6711 |
Remote Similarity |
NPD1201 |
Approved |
0.6688
|
Remote Similarity |
NPD3027 |
Phase 3 |